Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, ...

Drug discovery costs have always been high. Nvidia claims its AI can reduce costs by 70%, backed by a $1B partnership with ...

NVIDIA and Eli Lilly launch a $1 billion AI lab to speed drug discovery, improve manufacturing, and apply artificial ...

Eli Lilly (NYSE:LLY) shares climbed nearly 2% on Monday after the drugmaker announced a major artificial intelligence ...

Eli Lilly and NVIDIA have unveiled a first-of-its-kind AI co-innovation lab, aiming to solving the most complex bottlenecks ...

Silicon Valley microprocessing giant NVIDIA and pharma powerhouse Eli Lilly announced a five-year, $1 billion partnership to create a “Co-Innovation AI Lab” designed to address key challenges in AI ...

On Monday, AI powerhouse Nvidia kicked off this year’s J.P. Morgan Healthcare Conference by announcing new and expanded ...

Eli Lilly (LLY) is teaming up with Nvidia (NVDA) to invest in an artificial intelligence (AI) innovation lab. Eli Lilly CFO ...

Nvidia is turning its AI firepower toward the hardest problems in medicine, striking multibillion-dollar alliances with ...

At the JPMorgan Healthcare Conference in San Francisco, drugmakers signalled obesity drugs going mainstream, shifting from ...

Lilly and NVIDIA join forces for a $1B AI drug discovery lab, while Paramount fights for Warner Bros., Trump imposes tariffs, ...

Listen and subscribe to Stocks In Translation on Apple Podcasts, Spotify, or wherever you find your favorite podcast. Forget chatbots, here's where AI is really going to make strides in 2026. In this ...